Guideline for the use of beta-interferons in patients with multiple sclerosis--a South African proposal.
OBJECTIVE
To determine guidelines for use of beta-interferons in South African patients with multiple sclerosis.


METHODS
Review of existing international protocols. Opinions of South African neurologists who have an interest in multiple sclerosis.


CONCLUSIONS
The main indication for interferon use is the relapsing and remitting form of multiple sclerosis.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy; D013019:South Africa
D000276:Adjuvants, Immunologic; D016899:Interferon-beta